PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.\', \'Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.\', \'UCLA Children\'s Discovery and Innovation Institute, Mattel Children\'s Hospital UCLA, Department of Pediatrics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.\', \'Department of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.\', \'Department of Ecology and Evolutionary Biology, University of California, Irvine, Irvine, CA, USA.\', \'Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA.\', \'California Nanosystems Institute, UCLA, Los Angeles, CA, USA.\', \'Department of Bioengineering, UCLA Samueli School of Engineering, Los Angeles, CA, USA.\', \'Department of Molecular Biology Interdepartmental Program, UCLA, Los Angeles, CA, USA.\', \'Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.\', \'Eli and Edythe Broad Stem Cell Research Center, UCLA, Los Angeles, CA, USA.\', \'Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA. hchristofk@mednet.ucla.edu.\', \'Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA. hchristofk@mednet.ucla.edu.\', \'Eli and Edythe Broad Stem Cell Research Center, UCLA, Los Angeles, CA, USA. hchristofk@mednet.ucla.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-22166-4
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33767183
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all